Creative Medical Technology (CELZ) Institutional Ownership $5.40 -0.59 (-9.85%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$5.46 +0.06 (+1.11%) As of 02/21/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Creative Medical Technology (NASDAQ:CELZ)CurrentInstitutional OwnershipPercentage1.42%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$206.77KNumber ofInstitutional Sellers(last 12 months)0 Get CELZ Insider Trade Alerts Want to know when executives and insiders are buying or selling Creative Medical Technology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CELZ Institutional Buying and Selling by Quarter Creative Medical Technology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2025 Geode Capital Management LLC10,308$25K0.0%N/A0.589% 7/22/2024 Aaron Wealth Advisors LLC19,570$75K0.0%+19.3%1.450% 5/20/2024 Virtu Financial LLC16,374$85K0.0%N/A1.213% 4/25/2024 Aaron Wealth Advisors LLC16,400$85K0.0%N/A1.206% 1/24/2023 Aaron Wealth Advisors LLC100,000$38K0.0%N/A0.710% 5/13/2022 Sassicaia Capital Advisers LLC31,200$122K0.6%N/A0.479% 2/10/2022 Perkins Capital Management Inc.23,750$52K0.0%N/A0.375% (Data available from 1/1/2016 forward) CELZ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CELZ shares? During the previous two years, the following institutional investors and hedge funds held shares of Creative Medical Technology shares: Virtu Financial LLC ($85K), and Aaron Wealth Advisors LLC ($75K), Geode Capital Management LLC ($25K).Learn more on CELZ's institutional investors. What percentage of Creative Medical Technology stock is owned by institutional investors? 1.42% of Creative Medical Technology stock is owned by institutional investors. Learn more on CELZ's institutional investor holdings. Which institutional investors have been buying Creative Medical Technology stock? The following institutional investors have purchased Creative Medical Technology stock in the last 24 months: Aaron Wealth Advisors LLC ($19.57K), Virtu Financial LLC ($16.37K), and Geode Capital Management LLC ($10.31K). How much institutional buying is happening at Creative Medical Technology? Institutional investors have bought a total of 46,252 shares in the last 24 months. This purchase volume represents approximately $206.77K in transactions. Related Companies DURECT Major Shareholders Pluri Major Shareholders BioAtla Major Shareholders Tenax Therapeutics Major Shareholders Longeveron Major Shareholders Lakeshore Biopharma Major Shareholders Cara Therapeutics Major Shareholders Enlivex Therapeutics Major Shareholders Citius Pharmaceuticals Major Shareholders Bullfrog AI Major Shareholders This page (NASDAQ:CELZ) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.